Astellas Pharma, Inc. (ALPMY)
15.18
-0.01
(-0.07%)
USD |
OTCM |
Sep 18, 16:00
Astellas Pharma Price to Book Value : 2.277 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.277 |
| September 17, 2026 | 2.279 |
| September 16, 2026 | 2.215 |
| September 15, 2026 | 2.229 |
| September 14, 2026 | 2.228 |
| September 11, 2026 | 2.184 |
| September 10, 2026 | 2.133 |
| September 09, 2026 | 2.165 |
| September 08, 2026 | 2.204 |
| September 04, 2026 | 2.258 |
| September 03, 2026 | 2.321 |
| September 02, 2026 | 2.268 |
| September 01, 2026 | 2.235 |
| August 31, 2026 | 2.217 |
| August 28, 2026 | 2.210 |
| August 27, 2026 | 2.243 |
| August 26, 2026 | 2.253 |
| August 25, 2026 | 2.274 |
| August 24, 2026 | 2.256 |
| August 21, 2026 | 2.256 |
| August 20, 2026 | 2.244 |
| August 19, 2026 | 2.267 |
| August 18, 2026 | 2.163 |
| August 17, 2026 | 2.150 |
| August 14, 2026 | 2.208 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.181 |
| August 12, 2026 | 2.219 |
| August 11, 2026 | 2.234 |
| August 10, 2026 | 2.234 |
| August 07, 2026 | 2.219 |
| August 06, 2026 | 2.144 |
| August 05, 2026 | 2.118 |
| August 04, 2026 | 2.07 |
| August 03, 2026 | 2.050 |
| July 31, 2026 | 2.060 |
| July 30, 2026 | 2.163 |
| July 29, 2026 | 2.092 |
| July 28, 2026 | 2.048 |
| July 27, 2026 | 2.012 |
| July 24, 2026 | 1.981 |
| July 23, 2026 | 1.964 |
| July 22, 2026 | 1.994 |
| July 21, 2026 | 2.04 |
| July 20, 2026 | 1.988 |
| July 17, 2026 | 1.992 |
| July 16, 2026 | 1.982 |
| July 15, 2026 | 1.971 |
| July 14, 2026 | 1.983 |
| July 13, 2026 | 1.960 |
| July 10, 2026 | 1.988 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.285 |
| Daiichi Sankyo Co., Ltd. | 3.284 |
| Ono Pharmaceutical Co., Ltd. | 1.343 |
| Eisai Co., Ltd. | 1.59 |
| Chugai Pharmaceutical Co., Ltd. | 5.671 |
Price to Book Value Related Metrics
| PE Ratio | 11.58 |
| PS Ratio | 1.854 |
| PEG Ratio | 0.0363 |
| Price to Free Cash Flow | 8.822 |
| Price | 15.18 |
| Earnings Yield | 8.64% |
| Market Cap | 27.22B |
| PEGY Ratio | 0.0363 |
| Operating PE Ratio | 8.523 |
| Normalized PE Ratio | 11.58 |